Category Archives: MS Treatment

Madison, MS (PRWEB) July 11, 2014 Dr. Roger B. Parkes and R. Clarke Stewart of Periodontal Associates of Jackson, P.A. make it easier than ever before for area residents to treat their persistent gum disease and help prevent bone loss by offering the LANAP protocol, the first laser gum surgery cleared for patient use by the FDA. Patients searching for a periodontist near Madison, MS who may be concerned about traditional scalpel-based periodontal surgery can now have a procedure that restores their gum and bone health without any cuts or stitches and with minimal discomfort. The LANAP treatment utilizes the PerioLase MVP-7 laser which is able to differentiate between diseased and healthy gum tissue. It then essentially vaporizes the infected cells while leaving all others unaffected. This dramatically reduces the impact and pain during any recovery that patients experience. It also retains the maximum amount of healthy gum tissue and stimulates bone regrowth, which are critical to preventing the loss of teeth. Without enough gum and bone to hold them in place, teeth are at risk of extraction. When teeth are missing, the adjacent bone in the jaw no longer receives the stimulation that the natural tooth roots provide. This … Continue reading →

By MARILYNN MARCHIONE AP Chief Medical Writer A Mississippi girl born with the AIDS virus and in remission for years despite stopping treatment now shows signs that she still harbors HIV - and therefore is not cured. The news is a setback to hopes that very early treatment with powerful HIV drugs might reverse an infection that has seemed permanent once it takes hold. The girl is now nearly 4. As recently as March, doctors had said that she seemed free of HIV despite not having been on AIDS drugs for about two years. That was a medical first. But on Thursday, doctors said tests last week showed that she is no longer in remission. She is now back on treatment and is responding well, doctors said. The news is "obviously disappointing" and may have implications for a federal study that had been about to start testing early, aggressive treatment in such cases, said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. "We're going to take a good hard look at the study and see if it needs any modifications," either in terms of length and type of treatment or because of ethical concerns over … Continue reading →

EDMOND Pamela Gooch could not step out of bed on most days. Taking a shower exhausted her. Multiple sclerosis would not allow her to lift her 2-year-old son, Gooch said. On June 2, Gooch underwent an autologous stem cell transplant at Northwestern University in Chicago. Today, her chronic fatigue has vanished. Now I can do that and play with my kids and go to the park and have a picnic, said Gooch, a 41-year-old former Edmond pre-K teacher. MS remains an incurable autoimmune disease of the central nervous system. It occurs when the immune system attacks a persons myelin, a lining that protects nerve fibers. Symptoms of MS depend on where lesions form on the brain, optic nerve or spinal cord. More than 300,000 people in the United States with MS have symptoms ranging from fatigue, incontinence, dizziness, double vision, imbalance, numbness or paralysis, to speech problems and other sensory disorders. Gooch lives with progressive relapsing MS, a rare form of the disease. The pharmaceuticals used to treat MS did not prevent the explosion of brain lesions she had in April. Her right leg began to drag and she could barely walk to her driveway, she said. Her autologous stem … Continue reading →

Bench to Bedside: Multiple Sclerosis and Tysabri, Part 1 - Ted Yednock http://www.ibiology.org/ibioeducation/taking-courses/bench-to-bedside/tysabri-natalizumab-treatment-multiple-sclerosis.html Overview In the first of his two ... By: iBioEducation … Continue reading →

Rhett Wallace and Cassie Batten leave Epping police station. Photo: Joe Armao A heavily pregnant mother has been taken into police custody and questioned after admitting to using cannabis oil to treat her profoundly disabled three-year-old son's epilepsy. Police seized the treatment, made form a non psychoactive form of cannabis oil, and questioned Cassie Batten of Mernda, north-east of Melbourne at Epping police station on Thursday afternoon. The mother left the station with her partner Rhett Wallace following the questioning. It is understood no charges were laid. Ms Batten declined to comment outside the station, saying "I can't say much at this stage". Advertisement The couple could face charges at a later stage ofpossessing a drug of dependence and introducing a drug of dependence into the body of another. Ms Batten was interviewed by police after featuring in a current affairs program about the use ofa product called Mullaways Cannabinoid Tincture. During an interview on Channel Seven's Sunday Night,Ms Batten said her son Cooper's health had remarkably improveed after the use of the cannabis treatment. Born at 30 weeks, Cooper has endured a catalogue of health issues, among them cerebral palsy, epilepsy, infantile spasms and global delay development. Continued here: … Continue reading →

Using a novel screening platform to rapidly evaluate the cellular effects of 1,000 chemical compounds, a team led by UC San Francisco scientists has identified eight drugs that may stimulate nervous system repair in multiple sclerosis (MS). All eight compounds have previously been approved by the U.S. Food and Drug Administration (FDA) for the treatment of other conditions. One of the most promising agents is an antihistamine, though the scientists caution that MS patients should not use the drug until clinical trials have established whether it can safely and effectively treat MS, and if it does, what the proper dosages and treatment regimens would be. Because of the drugs emergence as a clear front-runner in the new study, a Phase 2 clinical trial to evaluate its effectiveness in MS is already underway at UCSF. A major unmet need in the development of therapeutics for repair in MS has been the ability to screen compounds in a high-throughput manner, said Jonah Chan, PhD, the Debbie and Andy Rachleff Distinguished Professor of Neurology at UCSF and senior author of the new study. Through a great deal of serendipity, combined with the hard work of outstanding students and colleagues, we have been able … Continue reading →

Alemtuzumab, also known as Lemtrada, can be used to treat NHS patients after it was ruled to be good value for money, despite a 56,000 price tag. An estimated 9,500 people in Scotland who have the more common relapsing remitting form of MS will become eligible to access the drug following the decision by the Scottish Medicines Consortium (SMC). Scotland has the highest prevalence of MS in the world, with more than 11,000 people living with the condition. Originally developed as a cancer treatment, alemtuzumab has been shown to reduce the frequency and severity of relapses, during which patients experience episodes of worsening neurological symptoms over a sustained period. The episodes can last weeks or months, may require hospital treatment and leave lingering health problems. Trials have shown that the drug also slows down progression of physical disability and offers added convenience to patients, who receive five infusions on consecutive days before returning a year later for three more daily doses, rather than an ongoing regime of injections. Dr Belinda Weller, a consultant neurologist at the Western General Hospital in Edinburgh, said that while patients would continue to be monitored closely, some would never need another alemtuzumab treatment following the … Continue reading →

The availability of cannabis-based medicine to relieve one of the main symptoms of multiple sclerosis is about to move a step closer. While regulatory approval has been recommended for around two years, legal changes are needed to allow its use as a treatment for muscle spasms suffered by patients with MS. The progressive, neurological condition affects 8,000 people in Ireland. The Department of Health said it will introduce regulations in the coming weeks which would enable authorised, cannabis-based medical products such as Sativex to be legally prescribed by medical practitioners and used by patients. Sativex is already in use for the relief of spasm symptoms by MS patients in a number of EU countries, including the UK. The availability of this and other cannabis-based treatments have long been sought by support organisation MS Ireland, which welcomed the prospect of revised legislation to allow their use. Ongoing research into the benefits of medicinal cannabis and cannabis-based medication extract for the symptoms of MS has shown the efficacy of such treatments to alleviate spasticity, sleep disorders, pain and other symptoms associated with MS, said chief executive Ava Battles. MS Ireland believes people with MS should have access to all and any appropriate … Continue reading →

After attending 16 doctors' appointments, Leigh Naylor, 32, was distraught when doctors found a cervical tumour and gave her nine months to live She raised 35,000 to have an alternative cancer treatment in Germany After three weeks of treatment, her tumour showed signs of shrinking Money has now run out and she needs 12,000 for every course of treatment Mrs Naylor said NHS misdiagnosed cancer as fibroids - taking legal action By Sarah Griffiths Published: 09:31 EST, 7 July 2014 | Updated: 13:16 EST, 7 July 2014 51 shares 147 View comments Leigh Naylor, (pictured) was distraught when doctors found a cervical tumour they had missed and gave her nine months to live A woman who claims doctors failed to diagnose her terminal cancer 16 times, raised 35,000 to fund treatment in Germany as she prepares to take legal action against the NHS. Leigh Naylor was distraught when medics revealed they had found cervical tumour, giving her nine months to live in March. The 32-year-old raised 35,000 to fund treatment in Germany, after doctors in the UK said all they could offer was a course of life-prolonging chemotherapy. More: Woman who claims NHS failed to spot her cancer raises 35,000 … Continue reading →

Wickenburg, Arizona (PRWEB) July 07, 2014 Remuda Ranch at The Meadows, a comprehensive treatment center specializing in eating and co-occurring disorders for women and girls, has appointed James Buck Runyan, MS, MFT, LPC, CEDSs, Clinical Director over the inpatient and residential LIFE campus. Runyan has over 20 years of experience working with eating disorders and addictions, including nearly seven years at Remuda Ranch holding clinical leadership positions. In addition to counseling and administrative work, he is a sought-after speaker and workshop facilitator on a vast array of eating disorder and family therapy related topics. Runyan has served on the International Association of Eating Disorder Professionals (IAEDP) Board of Directors since 2010, and is the current President of the Board of Directors for 2013-2014 in addition to a Fellow of IAEDP. Remuda Ranch at The Meadows is very fortunate to have Buck rejoin the organization, said Chris Diamond, Executive Director. Since starting his career at Remuda in the 90s, Buck has made a significant impact on the eating disorder industry through program development, his private practice, and service with the International Association of Eating Disorder Professionals. He will bring a wealth of experience and energy in the treatment of anorexia, bulimia, … Continue reading →